Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Oct 8, 2015Journal of psychopharmacology (Oxford, England)

Testing the updated questionnaire on mystical experiences during psilocybin sessions

AI simplified

Abstract

Data from 184 participants receiving controlled doses of psilocybin validate the 30-item revised Mystical Experience Questionnaire (MEQ30).

  • Confirmatory factor analysis shows the MEQ30 has reliable and valid measurement properties.
  • Structural equation models indicate that MEQ30 scores predict lasting changes in attitudes, behavior, and well-being related to psilocybin experiences.
  • The MEQ30 is associated with measuring the quality of mystical experiences effectively.
  • A scoring method for identifying a 'complete mystical experience' is validated within the MEQ30.
  • A stand-alone version of the MEQ30 is available for future research applications.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free